Na tej stronie
DXCM DexCom, Inc. - Common Stock
NASDAQ · Health Care · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Lip 30, 2026
$85,36
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$54,1152tyg. minimum
$92,5952tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$32.21B
P/E (TTM)
33.9
EPS (TTM)
$2.52
Przychody (TTM)
$4.97B
Twoje odznaki
Zakres 52 tyg.
$54–$93
Ocena Analityków
BUY
Cena Docelowa
$95
P/E
33.9
ROE
38.5%
Marża Zysku Netto
20.1%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
DXCM Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$85.36
Kapitalizacja Rynkowa (MRQ)
$32.21B
P/E (TTM)
33.9
EPS (TTM)
$2.52
Przychody (TTM)
$4.97B
ROE (TTM)
38.5%
Zakres 52 tyg.
$54–$93
DXCM Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
Podziały akcji
| Data ex-dywidendy | Podział | Typ |
|---|---|---|
| 13 czerwca 2022 | 4-for-1 | Naprzód |
O DexCom, Inc. - Common Stock Przegląd firmy z Wikipedii
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.
History
Dexcom was founded in 1999 by Scott Glenn, John Burd, Lauren Otsuki, Ellen Preston and Bret Megargel. In 2006, Dexcom received U.S. Food and Drug Administration (FDA) approval and launched the Dexcom STS Continuous Glucose Monitoring System, which is a three-day sensor that provides up to 288 glucose measurements for every 24 hours. Dexcom received approval of the second-generation product, the Seven Continuous Glucose Monitoring System, in May 2007. This device improved on accuracy and extended use from three to seven days. In 2008, Dexcom announced two consumer development agreements with Insulet Corporation and Animas Corporation as well as a development agreement with Edwards Lifesciences for a continuous glucose monitor in the intensive care unit hospital environment.
During February 2009, Dexcom received approval for the Seven Plus Continuous Glucose Monitor, its new continuous glucose monitoring system, from the FDA. This product received a CE mark in November 2009. In 2013, development work for integration with Insulet was discontinued. Dexcom entered a non-exclusive agreement with Tandem Diabetes Care, Inc. in 2015 to allow the integration of its forthcoming G5 and G6 continuous glucose monitoring systems into Tandem's insulin pumps. The G5 was approved in 2016 by the FDA for use as a standalone device, while the G6 gained approval in 2018.
Dexcom's first G-series CGM, the G4 Platinum, received a CE mark and FDA approval in 2012 for adults ages 18 and over. This device improved hypoglycemic accuracy by 30%. It also offered a longer range of transmission between the sensor and receiver, as well as a color LCD. The G4 Platinum was approved by the FDA for use in patients ages 2–17 in February 2014. Dexcom received FDA approval in January 2015 for the G4 Platinum with Share, which enabled the sharing of CGM data with up to five other people using the "Share" and "Follow" smartphone apps.
The Dexcom G5 was approved in August 2015 by the FDA for use as a standalone device, the G5 has Bluetooth integrated into its transmitter, enabling it to send data to a mobile device. This allows for use of the device without the standalone receiver. The Dexcom G5 received a CE mark in September 2015.
Dexcom went public in 2005 and is listed on the Nasdaq Global Select Market stock exchange under the ticker symbol DXCM. On April 20, 2020, Dexcom became a component of the Nasdaq-100, replacing American Airlines Group in the index.
The Dexcom G7 was approved in December 2022 by the FDA for use as a standalone device. The Dexcom G7 15-Day is the most accurate currently approved CGM in the U.S.
Awards and recognition
In October 2024, Time Magazine named Dexcom Stelo's over-the-counter glucose monitor one of the year's best inventions.
Partnerships
Dexcom entered into a partnership in 2015 with Google Life Sciences (which subsequently became Verily) to develop the Dexcom G7
Dexcom entered a non-exclusive agreement with Tandem Diabetes Care, Inc. in 2015 to allow the integration of its new G5 and G6 continuous glucose monitoring systems into Tandem's insulin pumps. Tandem Diabetes Care received FDA approval in December 2019 for Control-IQ, a closed-loop technology that uses Tandem's t:slim X2 insulin pump and the Dexcom G6 "to automatically increase, decrease, or stop the delivery of insulin in response to the glucose levels of people with Type 1 diabetes."
In June 2019, Dexcom announced a collaboration with Companion Medical to enable the exchange of CGM data from Dexcom with insulin data from InPen into both companies' software applications.
Dexcom entered into a partnership with Livongo, a digital chronic care management company, in January 2020 to share CGM data from the Dexcom G6 with Livongo's platform. This integration allowed Livongo to incorporate the CGM data along with other patient data.
In February 2020, Dexcom and Insulet Corporation signed a non-exclusive, global agreement to combine current and future Dexcom continuous glucose monitoring systems with Insulet's tubeless insulin delivery Pod into the Omnipod Horizon System for automated insulin delivery. This allowed the ability to adjust insulin doses based on Insulet's algorithm or through their smartphone.
The company also announced in March 2020 a partnership with Welldoc to integrate G6 CGM data with BlueStar, a digital platform for diabetes management.
In November 2024, Dexcom announced a "strategic partnership" and data exchange with Oura.
Venture capital arm
In early 2021, Dexcom launched Dexcom Ventures, a venture capital arm focused on emerging continuous glucose monitoring technologies and devices measuring the levels of other types of substances and analytes. In practice, Dexcom Ventures has also invested in cybersecurity platforms for the software used in medical devices.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
sektorHealth Care
branżaHealth Care
pracownicy11 000
krajUS
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$4.66B2016-12-31 → 2025-12-31
EPS$2.092017-12-31 → 2025-12-31
Wolny przepływ pieniężny$1.08B2016-12-31 → 2025-12-31
Marża netto20.1%2018-12-31 → 2025-12-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | DXCM | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | 33.9średnia z 5 lat ≈114.7 | ≈114.7 | 28.0 | Wartość godziwa | |
| P/S (TTM) | 6.5średnia z 5 lat ≈9.3 | ≈9.3 | 4.8 | Zawyżona wycena | |
| P/B (MRQ) | 12.3średnia z 5 lat ≈14.6 | ≈14.6 | 4.7 | Zawyżona wycena | |
| Cena / FCF (TTM) | 22.9średnia z 5 lat ≈110.6 | ≈110.6 | · | · | |
| Cena / Przepływy pieniężne (TTM) | 18.4średnia z 5 lat ≈41.4 | ≈41.4 | 21.9 | Niedowartościowany | |
| Cena / Wartość księgowa materialna (MRQ) | 12.8średnia z 5 lat ≈15.9 | ≈15.9 | · | · | |
| PEG Ratio (Współczynnik PEG) | ≈3.6 | · | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | DXCM | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża brutto (TTM) | 62.5%średnia z 5 lat ≈63.4% | ≈63.4% | 64.0% | Słaby | |
| Marża Operacyjna (TTM) | 22.9%średnia z 5 lat ≈15.0% | ≈15.0% | 23.0% | Zgodnie z | |
| Marża EBITDA (TTM) | 28.2%średnia z 5 lat ≈20.1% | ≈20.1% | 27.1% | Zgodnie z | |
| Marża przed opodatkowaniem (TTM) | 25.8%średnia z 5 lat ≈16.2% | ≈16.2% | 21.6% | Zgodnie z | |
| Marża Zysku Netto (TTM) | 20.1%średnia z 5 lat ≈13.0% | ≈13.0% | 15.3% | Najwyższa półka | |
| ROA (TTM) | 14.5%średnia z 5 lat ≈8.3% | ≈8.3% | 7.5% | Najwyższa półka | |
| ROE (TTM) | 38.5%średnia z 5 lat ≈21.9% | ≈21.9% | 14.1% | Najwyższa półka | |
| ROIC | 25.5%średnia z 5 lat ≈19.4% | ≈19.4% | 9.9% | Najwyższa półka |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | DXCM | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Wskaźnik bieżący (MRQ) | 1.7średnia z 5 lat ≈2.7 | ≈2.7 | 1.5 | Zgodnie z | |
| Quick Ratio (Wskaźnik Szybkości) | 1.0średnia z 5 lat ≈1.1 | ≈1.1 | 0.8 | Silna płynność |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | DXCM | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 15.6%średnia z 5 lat ≈19.5% | ≈19.5% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 17.0%średnia z 5 lat ≈19.5% | ≈19.5% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 19.3% | · | · | · | |
| EPS YoY | 47.2%średnia z 5 lat ≈21.9% | ≈21.9% | · | · | |
| Net Income YoY (Zysk Netto R/R) | 45.1%średnia z 5 lat ≈21.4% | ≈21.4% | · | · | |
| EPS CAGR 3Y (CAGR z EPS 3 lata) | 36.6%średnia z 5 lat ≈24.9% | ≈24.9% | · | · | |
| EPS CAGR 5Y (CAGR z EPS 5 lat) | 9.5% | · | · | · | |
| Net Income CAGR 3Y (CAGR z zysku netto 3 lata) | 34.8%średnia z 5 lat ≈24.3% | ≈24.3% | · | · | |
| Net Income CAGR 5Y (CAGR z zysku netto 5 lat) | 8.8% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | DXCM | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.7średnia z 5 lat ≈0.6 | ≈0.6 | 0.5 | Najwyższa półka | |
| Inventory Turnover (Rotacja zapasów) | 3.2średnia z 5 lat ≈3.0 | ≈3.0 | 2.4 | Najwyższa półka | |
| Receivables Turnover (Rotacja należności) | 4.2średnia z 5 lat ≈4.5 | ≈4.5 | 6.1 | Słaby | |
| Revenue / Employee (Przychody / pracownika) | ≈$423.8K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
9.1%
Następny raport
Paź 28, 2026
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Lip 28, 2026 | $0.70 | $0.62 | 12.4% |
| 31 marca 2026 | $0.56 | $0.48 | 17.0% | |
| 31 grudnia 2025 | $0.56 | $0.48 | 17.0% | |
| 30 września 2025 | $0.61 | $0.58 | 5.3% | |
| 30 czerwca 2025 | $0.48 | $0.45 | 6.8% | |
| 31 marca 2025 | $0.32 | $0.33 | -4.1% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B | $1.93B | $1.48B | $1.03B | $718M | $573M | · | · | |
| Cost of Revenue | $1.86B | $1.59B | $1.33B | $1.03B | $768M | $647M | $544M | $368M | $226M | $195M | $124M | $83M | |
| Gross Profit | $2.80B | $2.44B | $2.29B | $1.88B | $1.68B | $1.28B | $932M | $664M | $492M | $378M | $278M | $176M | |
| R&D Expense | $599M | $552M | $506M | $484M | $517M | $360M | $274M | $200M | $185M | $156M | $138M | $69M | |
| SG&A Expense | $1.29B | $1.29B | $1.19B | $1.01B | $810M | $618M | $516M | $433M | $349M | $286M | $198M | $128M | |
| Operating Expenses | $1.89B | $1.84B | $1.69B | $1.49B | $1.41B | $981M | $789M | $850M | $535M | $442M | $336M | $198M | |
| Operating Income | $912M | $600M | $598M | $391M | $266M | $300M | $142M | $-186M | $-42M | $-64M | $-57M | $-22M | |
| Interest Expense | · | · | $20M | $19M | $19M | $18M | $60M | $23M | $13M | $700.0K | $400.0K | $800.0K | |
| Interest Income | · | · | · | · | · | · | · | · | $3M | $400.0K | $0 | $0 | |
| Other Non-op | $177M | $109M | $113M | $-400.0K | $-9M | $16M | $26M | $2M | $7M | $-700.0K | $0 | $0 | |
| Pretax Income | $1.09B | $709M | $710M | $391M | $257M | $298M | $104M | $-126M | $-49M | $-65M | $-58M | $-22M | |
| Income Tax | $252M | $133M | $169M | $50M | $40M | $-252M | $3M | $600.0K | $2M | $700.0K | $100.0K | $100.0K | |
| Net Income | $836M | $576M | $542M | $341M | $217M | $550M | $101M | $-127M | $-50M | $-66M | $-58M | $-22M | |
| EPS (Basic) | $2.14 | $1.46 | $1.40 | $0.88 | $0.56 | $1.46 | $1.11 | $-1.44 | $-0.58 | · | · | · | |
| EPS (Diluted) | $2.09 | $1.42 | $1.30 | $0.82 | $0.53 | $1.33 | $1.10 | $-1.44 | $-0.58 | · | · | · | |
| Shares (Basic) | 390,200,000 | 393,600,000 | 386,000,000 | 389,400,000 | 386,900,000 | 377,500,000 | 91,100,000 | 88,200,000 | 86,300,000 | · | · | · | |
| Shares (Diluted) | 405,500,000 | 412,700,000 | 425,500,000 | 427,500,000 | 428,800,000 | 420,400,000 | 92,300,000 | 88,200,000 | 86,300,000 | · | · | · | |
| EBITDA | $1.16B | $818M | $784M | $547M | $368M | $367M | $191M | $-157M | $-26M | $-49M | $-46M | $-13M |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $918M | $606M | $566M | $642M | $1.05B | $818M | $446M | $1.14B | $442M | $94M | $86M | $72M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $93M | $23M | · | · | |
| Receivables | $1.22B | $1.01B | $974M | $713M | $514M | $428M | $286M | $227M | $134M | $102M | $74M | $42M | |
| Inventory | $629M | $543M | $560M | $307M | $357M | $235M | $120M | $71M | $45M | $45M | $35M | $16M | |
| Prepaid Expense | $189M | $174M | $168M | $193M | $82M | $54M | $30M | $16M | $17M | $9M | $7M | $4M | |
| Other Current Assets | $29M | $29M | $49M | $27M | $27M | · | · | · | · | · | · | · | |
| Current Assets | $4.03B | $4.30B | $4.43B | $3.67B | $3.68B | $3.42B | $1.97B | $1.70B | $745M | $280M | $231M | $146M | |
| PP&E (Net) | · | · | · | $1.06B | $802M | $515M | $321M | $183M | $146M | $109M | $55M | $31M | |
| PP&E (Gross) | · | · | · | $1.42B | $1.03B | $670M | $426M | $263M | $200M | $157M | $93M | $64M | |
| Accum. Depreciation | · | · | · | $363M | $232M | $154M | $105M | $80M | $55M | $47M | $38M | $33M | |
| Goodwill | $24M | $23M | $25M | $26M | $26M | $19M | $19M | $19M | $12M | $11M | $4M | $3M | |
| Intangibles | $71M | $103M | $134M | $173M | $32M | · | · | · | · | $200.0K | $2M | $3M | |
| Other Non-current Assets | $279M | $173M | $75M | $47M | $10M | $21M | $14M | $15M | $2M | $2M | $100.0K | $600.0K | |
| Total Assets | $6.34B | $6.48B | $6.26B | $5.39B | $4.93B | $4.29B | $2.40B | $1.92B | $904M | $403M | $292M | $185M | |
| Current Liabilities | $2.14B | $2.93B | $1.56B | $1.84B | $721M | $614M | $360M | $222M | $139M | $102M | $67M | $41M | |
| Capital Leases | $73M | $65M | $80M | $95M | $99M | $102M | $72M | $0 | · | · | · | · | |
| Deferred Tax | · | · | · | $5M | $6M | $0 | · | · | · | · | · | · | |
| Other Non-current Liabilities | $137M | $148M | $126M | $128M | $90M | $81M | $20M | $20M | $18M | $17M | $4M | $2M | |
| Total Liabilities | $3.59B | $4.38B | $4.20B | $3.26B | $2.89B | $2.46B | $1.51B | $1.25B | $485M | $119M | $71M | $44M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $5M | |
| Retained Earnings | $2.43B | $1.60B | $1.02B | $480M | $139M | $-78M | $-696M | $-799M | $-672M | $-621M | $-555M | $-498M | |
| Treasury Stock | $2.08B | $1.58B | $2.45B | $595M | $206M | $100M | $100M | $100M | $0 | · | · | · | |
| AOCI | $115M | $-8M | $-17M | $-12M | $500.0K | $3M | $2M | $2M | $-3M | $-1M | $-300.0K | $-100.0K | |
| Stockholders' Equity | $2.75B | $2.10B | $2.07B | $2.13B | $2.04B | $1.55B | $883M | $663M | $419M | $284M | $221M | $140M | |
| Liabilities + Equity | $6.34B | $6.48B | $6.26B | $5.39B | $4.93B | $4.29B | $2.40B | $1.92B | $904M | $403M | $292M | $185M | |
| Shares Outstanding | 384,800,000 | 390,700,000 | 385,400,000 | 386,300,000 | 388,000,000 | 384,400,000 | 366,400,000 | 90,000,000 | 87,000,000 | 84,600,000 | 81,700,000 | 77,300,000 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $252M | $218M | $186M | $156M | $102M | $67M | $49M | $29M | $16M | $15M | $11M | $8M | |
| Stock-based Comp | $160M | $170M | $151M | $126M | $113M | $119M | $103M | $102M | $106M | $111M | $83M | $50M | |
| Deferred Tax | $182M | $-44M | $-55M | $-22M | $16M | $-260M | $200.0K | $-2M | $0 | $-200.0K | $0 | $0 | |
| Amort. of Intangibles | $4M | $7M | $8M | $8M | $4M | $2M | · | · | · | $700.0K | $500.0K | $600.0K | |
| Restructuring | · | · | · | · | · | · | $8M | · | · | · | · | · | |
| Other Non-cash | $11M | $69M | $-75M | $68M | $77M | $73M | $62M | $122M | $20M | $-4M | $13M | $-12M | |
| Operating Cash Flow | $1.44B | $990M | $748M | $670M | $442M | $476M | $314M | $123M | $92M | $56M | $49M | $24M | |
| CapEx | $364M | $359M | $237M | $365M | $389M | $199M | $180M | $67M | $66M | $56M | $33M | $16M | |
| Investing Cash Flow | $536M | $-208M | $-507M | $-522M | $-216M | $-1.02B | $-1.02B | $-140M | $-144M | $-56M | $-52M | $-17M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $0 | $-2M | $-2M | $-2M | |
| Stock Issued | $28M | $28M | $27M | $22M | $20M | $15M | $12M | $11M | $10M | $10M | $19M | $24M | |
| Stock Repurchased | $500M | $750M | $689M | $558M | $0 | $0 | $0 | $100M | $0 | $0 | · | · | |
| Net Stock Activity | $-472M | $-722M | $-662M | $-535M | $20M | $15M | $12M | $-89M | $10M | $10M | $19M | $24M | |
| Financing Cash Flow | $-1.69B | $-735M | $-319M | $-552M | $10M | $912M | $11M | $710M | $399M | $8M | $17M | $22M | |
| Net Change in Cash | $312M | $40M | $-76M | $-410M | $235M | $372M | $-691M | $696M | $347M | $8M | $14M | $29M | |
| Taxes Paid | $94M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.08B | $631M | $512M | $305M | $53M | $277M | $134M | $56M | $26M | $500.0K | $16M | $7M | |
| Levered FCF | · | · | $496M | $288M | $-36M | $91M | $76M | $33M | $13M | $-207.6K | $15M | $7M |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 60.1% | 60.5% | 63.2% | 64.7% | 68.6% | 66.4% | 63.1% | 64.4% | · | · | · | · | |
| Operating Margin | 19.6% | 14.9% | 16.5% | 13.4% | 10.9% | 15.5% | 9.6% | -18.1% | · | · | · | · | |
| Net Margin | 17.9% | 14.3% | 14.9% | 11.7% | 6.3% | 25.6% | 6.9% | -12.3% | · | · | · | · | |
| Pretax Margin | 23.4% | 17.6% | 19.6% | 13.4% | 7.1% | 11.7% | 7.1% | -12.3% | · | · | · | · | |
| EBITDA Margin | 25.0% | 20.3% | 21.6% | 18.8% | 15.0% | 19.0% | 12.9% | -15.2% | · | · | · | · | |
| ROA | 13.0% | 9.0% | 9.3% | 6.6% | 3.4% | 14.8% | 4.7% | -9.0% | -7.7% | -18.9% | -24.2% | -14.6% | |
| ROE | 31.4% | 28.2% | 25.0% | 17.2% | 7.4% | 29.7% | 12.3% | -20.7% | -14.3% | -26.0% | -31.9% | -20.0% | |
| ROIC | 25.5% | 23.2% | 22.0% | 16.0% | 10.5% | 36.0% | 15.6% | -28.2% | -10.5% | -22.8% | -25.9% | -15.4% |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.5 | 2.8 | 2.0 | 5.1 | 5.6 | 5.5 | 7.6 | 5.4 | 2.7 | 3.5 | 3.6 | |
| Quick Ratio | 1.0 | 0.5 | 1.0 | 0.7 | 2.2 | 2.0 | 2.0 | 6.1 | 4.8 | 2.1 | 2.4 | 1.8 | |
| Interest Coverage | · | · | 29.4 | 21.0 | 2.6 | 3.5 | 2.4 | -8.2 | -3.3 | -91.3 | -142.8 | -26.9 |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.7 | 0.7 | · | · | · | · | |
| Inventory Turnover | 3.2 | 2.9 | 3.1 | 3.1 | 2.6 | 3.6 | 5.7 | 6.3 | 5.0 | 4.8 | 4.8 | 6.6 | |
| Receivables Turnover | 4.2 | 4.1 | 4.3 | 4.7 | 5.2 | 5.4 | 5.8 | 5.7 | · | · | · | · |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.14 | $5.38 | $5.37 | $5.52 | $23.21 | $19.01 | $9.64 | $7.37 | $4.82 | $3.35 | $2.71 | $1.81 | |
| Revenue / Share | $11.50 | $9.77 | $8.51 | $6.81 | $24.46 | $19.76 | $15.99 | · | · | · | · | · | |
| Cash Flow / Share | $3.55 | $2.40 | $1.76 | $1.57 | $4.42 | $4.88 | $3.41 | · | · | · | · | · | |
| Cash / Share | $2.38 | $1.55 | $1.47 | $1.66 | $10.85 | $8.51 | $4.87 | $12.63 | $5.07 | $1.12 | $1.05 | $0.93 | |
| EPS (TTM) | $2.09 | $1.42 | $1.30 | $0.82 | $0.53 | $1.33 | $1.10 | $-1.44 | $-0.58 | · | · | · |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 15.6% | 11.3% | 24.5% | 18.8% | 27.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 17.0% | 18.1% | 23.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 19.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 47.2% | 9.2% | 58.5% | 54.7% | -60.2% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 36.6% | 38.9% | -0.76% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 9.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 45.1% | 6.4% | 58.7% | 57.3% | -60.5% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 34.8% | 38.5% | -0.50% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 8.8% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B | $1.93B | $1.48B | $1.03B | $718M | $573M | $402M | $259M | |
| Net Income TTM | $836M | $576M | $542M | $341M | $217M | $550M | $101M | $-127M | $-50M | $-66M | $-58M | $-22M | |
| Market Cap | $25.54B | $30.38B | $47.82B | $43.74B | $13.02B | $8.88B | $5.01B | $2.70B | $1.25B | $1.26B | $1.67B | $1.06B | |
| P/E | 31.8 | 54.8 | 95.5 | 138.1 | 253.3 | 69.5 | 49.7 | -20.8 | -24.7 | · | · | · | |
| P/S | 5.5 | 7.5 | 13.2 | 15.0 | 5.3 | 4.6 | 3.4 | 2.6 | 1.7 | 2.2 | 4.2 | 4.1 | |
| P/B | 9.3 | 14.5 | 23.1 | 20.5 | 5.8 | 4.9 | 5.7 | 4.1 | 3.0 | 4.4 | 7.6 | 7.6 | |
| P / Tangible Book | 9.6 | 15.4 | 25.1 | 22.6 | 6.6 | 5.8 | · | · | · | · | · | · | |
| P / Cash Flow | 17.7 | 30.7 | 63.9 | 65.3 | 29.4 | 18.7 | 15.9 | 21.9 | 13.6 | 22.5 | 34.1 | 45.1 | |
| P / FCF | 23.7 | 48.2 | 93.4 | 143.6 | 244.3 | 32.1 | 37.2 | 48.0 | 48.0 | 2525.3 | 106.5 | 143.8 | |
| Earnings Yield | 3.1% | 1.8% | 1.1% | 0.72% | 0.39% | 1.4% | 2.0% | -4.8% | -4.0% | · | · | · |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.31B | $1.19B | $1.26B | $1.21B | $1.16B | $1.04B | $1.11B | $994M | $1.00B | $921M | $1.03B | $975M | $871M | $742M | $815M | $770M | |
| Cost of Revenue | $478M | $442M | $467M | $478M | $468M | $447M | $458M | $400M | $378M | $359M | $378M | $352M | $325M | $279M | $274M | $275M | |
| Gross Profit | $830M | $750M | $793M | $731M | $689M | $589M | $656M | $594M | $627M | $562M | $657M | $623M | $546M | $463M | $541M | $494M | |
| R&D Expense | $153M | $145M | $148M | $158M | $148M | $145M | $140M | $135M | $136M | $142M | $136M | $131M | $119M | $119M | $116M | $110M | |
| SG&A Expense | $359M | $350M | $322M | $331M | $328M | $310M | $327M | $306M | $333M | $319M | $304M | $286M | $299M | $296M | $305M | $235M | |
| Operating Expenses | $512M | $495M | $470M | $489M | $476M | $455M | $467M | $442M | $469M | $461M | $440M | $418M | $418M | $415M | $416M | $347M | |
| Operating Income | $318M | $255M | $323M | $242M | $213M | $134M | $189M | $152M | $158M | $101M | $217M | $206M | $128M | $47M | $125M | $148M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $5M | · | $5M | $6M | $5M | · | $5M | |
| Other Non-op | $-800.0K | $14M | $18M | $110M | $28M | $21M | $22M | $25M | $30M | $31M | $29M | $35M | $31M | $17M | $-1M | $-1M | |
| Pretax Income | $318M | $270M | $341M | $352M | $241M | $154M | $211M | $177M | $188M | $132M | $246M | $240M | $159M | $64M | $133M | $146M | |
| Income Tax | $68M | $70M | $73M | $68M | $61M | $49M | $60M | $43M | $44M | $-14M | $-10M | $120M | $43M | $16M | $41M | $45M | |
| Net Income | $249M | $200M | $267M | $284M | $180M | $105M | $152M | $135M | $144M | $146M | $256M | $121M | $116M | $49M | $92M | $101M | |
| EPS (Basic) | $0.65 | $0.52 | $0.68 | $0.73 | $0.46 | $0.27 | $0.38 | $0.34 | $0.36 | $0.38 | $0.66 | $0.31 | $0.30 | $0.13 | $0.24 | $0.26 | |
| EPS (Diluted) | $0.64 | $0.51 | $0.67 | $0.70 | $0.45 | $0.27 | $0.37 | $0.34 | $0.35 | $0.36 | $0.61 | $0.29 | $0.28 | $0.12 | $0.23 | $0.24 | |
| Shares (Basic) | 382,200,000 | 385,100,000 | · | 391,100,000 | 392,100,000 | 391,100,000 | · | 394,200,000 | 399,200,000 | 390,200,000 | · | 386,600,000 | 386,700,000 | 386,700,000 | · | 389,800,000 | |
| Shares (Diluted) | 390,100,000 | 393,600,000 | · | 407,400,000 | 408,200,000 | 407,500,000 | · | 410,200,000 | 416,800,000 | 416,700,000 | · | 426,800,000 | 431,500,000 | 418,500,000 | · | 425,800,000 | |
| EBITDA | $386M | $322M | · | $306M | $276M | $194M | · | $152M | $158M | $154M | · | $206M | $128M | $89M | · | $148M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.10B | $1.12B | $918M | $1.84B | $1.16B | $905M | $606M | $621M | $939M | $851M | $566M | $644M | $1.19B | $623M | $642M | $698M | |
| Receivables | $1.26B | $1.09B | $1.22B | $1.11B | $1.35B | $1.16B | $1.01B | $1.00B | $945M | $979M | · | $786M | $751M | $637M | · | $564M | |
| Inventory | $726M | $694M | $629M | $604M | $571M | $538M | $543M | $586M | $570M | $589M | · | $499M | $421M | $366M | · | $311M | |
| Prepaid Expense | $156M | $134M | $189M | $184M | $181M | $159M | $174M | $182M | $212M | $156M | · | $174M | $195M | $198M | · | $152M | |
| Other Current Assets | $37M | $30M | $29M | $34M | $46M | $43M | $29M | $48M | $48M | $40M | · | $41M | $58M | $43M | · | $28M | |
| Current Assets | $4.09B | $4.33B | $4.03B | $5.22B | $5.03B | $4.55B | $4.30B | $4.26B | $4.85B | $4.62B | · | $4.70B | $5.00B | $3.77B | · | $3.40B | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.08B | · | $1.00B | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.47B | · | $1.34B | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | $394M | · | $338M | |
| Goodwill | $24M | $24M | $24M | $24M | $24M | $23M | $23M | $24M | $23M | $23M | · | $25M | $26M | $26M | · | $25M | |
| Intangibles | $102M | $63M | $71M | $79M | $87M | $95M | $103M | $106M | $114M | $123M | · | $144M | $154M | $164M | · | $24M | |
| Other Non-current Assets | $274M | $286M | $279M | $276M | $176M | $168M | $173M | $88M | $83M | $78M | · | $74M | $67M | $57M | · | $34M | |
| Total Assets | $6.46B | $6.63B | $6.34B | $7.50B | $7.33B | $6.75B | $6.48B | $6.35B | $6.80B | $6.48B | · | $6.60B | $6.82B | $5.52B | · | $4.90B | |
| Current Liabilities | $2.36B | $2.22B | $2.14B | $3.34B | $3.31B | $3.04B | $2.93B | $1.73B | $1.72B | $1.59B | · | $1.68B | $2.07B | $1.86B | · | $900M | |
| Capital Leases | $83M | $69M | $73M | $51M | $55M | $60M | $65M | $71M | $77M | $76M | · | $83M | $87M | $90M | · | $82M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $5M | $5M | $5M | · | $5M | |
| Other Non-current Liabilities | $151M | $142M | $137M | $147M | $152M | $150M | $148M | $130M | $128M | $129M | · | $134M | $133M | $130M | · | $123M | |
| Total Liabilities | $3.83B | $3.68B | $3.59B | $4.77B | $4.75B | $4.49B | $4.38B | $4.37B | $4.36B | $4.24B | · | $4.33B | $4.72B | $3.28B | · | $3.07B | |
| Retained Earnings | $2.88B | $2.63B | $2.43B | $2.17B | $1.88B | $1.70B | $1.60B | $1.45B | $1.31B | $1.17B | · | $765M | $644M | $528M | · | $388M | |
| Treasury Stock | $2.73B | $2.12B | $2.08B | $1.77B | $1.58B | $1.58B | $1.58B | $1.58B | $832M | $1.39B | · | $2.08B | $784M | $595M | · | $595M | |
| AOCI | $90M | $106M | $115M | $82M | $84M | $2M | $-8M | $63M | $-38M | $-37M | · | $-36M | $-29M | $-6M | · | $-41M | |
| Stockholders' Equity | $2.62B | $2.96B | $2.75B | $2.73B | $2.57B | $2.27B | $2.10B | $1.98B | $2.43B | $2.25B | $2.07B | $2.27B | $2.10B | $2.23B | $2.13B | $1.82B | |
| Liabilities + Equity | $6.46B | $6.63B | $6.34B | $7.50B | $7.33B | $6.75B | $6.48B | $6.35B | $6.80B | $6.48B | · | $6.60B | $6.82B | $5.52B | · | $4.90B | |
| Shares Outstanding | 377,400,000 | 385,900,000 | 384,800,000 | 390,000,000 | 392,200,000 | 392,100,000 | 390,700,000 | 390,600,000 | 400,700,000 | 396,100,000 | 385,400,000 | 386,400,000 | 386,100,000 | 387,600,000 | 386,300,000 | 386,200,000 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $68M | $67M | $65M | $64M | $63M | $60M | $58M | $55M | $52M | $52M | $52M | $48M | $44M | $42M | $36M | $39M | |
| Stock-based Comp | $39M | $43M | $35M | $45M | $45M | $34M | $43M | $43M | $45M | $39M | $37M | $39M | $40M | $35M | $34M | $31M | |
| Deferred Tax | $-300.0K | $300.0K | $79M | $118M | $-9M | $-6M | $24M | $-12M | $-15M | $-42M | $82M | $-85M | $-42M | $-9M | $32M | $-34M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | $3M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-cash | · | $215M | · | · | · | $-10M | · | · | · | $13M | · | · | · | $39M | · | · | |
| Operating Cash Flow | $269M | $526M | $294M | $660M | $303M | $184M | $301M | $200M | $279M | $209M | $134M | $269M | $190M | $155M | $132M | $293M | |
| CapEx | $85M | $77M | $102M | $80M | $94M | $87M | $125M | $111M | $66M | $57M | $52M | $50M | $59M | $75M | $64M | $108M | |
| Investing Cash Flow | $330M | $-298M | $307M | $193M | $-64M | $100M | $-304M | $210M | $-189M | $75M | $415M | $-180M | $-556M | $-187M | $-194M | $229M | |
| Stock Issued | $0 | $13M | $0 | $14M | $0 | $14M | $0 | $15M | $0 | $13M | $0 | $14M | $0 | $12M | $0 | $12M | |
| Stock Repurchased | · | · | $313M | $187M | · | · | $0 | $750M | · | · | $500M | $0 | · | · | $0 | $558M | |
| Net Stock Activity | · | $13M | · | · | · | $14M | · | · | · | $13M | · | · | · | $12M | · | · | |
| Financing Cash Flow | $-607M | $-25M | $-1.52B | $-175M | $-2M | $12M | $-2M | $-736M | $-1M | $5M | $-632M | $-637M | $940M | $11M | $-1M | $-552M | |
| Net Change in Cash | $-13M | $199M | $-918M | $677M | $254M | $299M | $-15M | $-318M | $88M | $285M | $-77M | $-551M | $572M | $-19M | $-56M | $-37M | |
| Free Cash Flow | · | $449M | · | · | · | $97M | · | · | · | $152M | · | · | · | $81M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $147M | · | · | · | $77M | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 63.4% | 62.9% | · | 60.5% | 59.5% | 56.9% | · | 59.7% | 62.4% | 61.0% | · | 63.9% | 62.7% | 62.4% | · | 64.2% | |
| Operating Margin | 24.3% | 21.4% | · | 20.1% | 18.4% | 12.9% | · | 15.3% | 15.7% | 11.0% | · | 21.1% | 14.7% | 6.4% | · | 19.2% | |
| Net Margin | 19.0% | 16.7% | · | 23.5% | 15.5% | 10.2% | · | 13.5% | 14.3% | 15.9% | · | 12.4% | 13.3% | 6.6% | · | 13.2% | |
| Pretax Margin | 24.3% | 22.6% | · | 29.1% | 20.8% | 14.9% | · | 17.8% | 18.7% | 14.4% | · | 24.7% | 18.3% | 8.7% | · | 19.0% | |
| EBITDA Margin | 29.5% | 27.1% | · | 25.3% | 23.8% | 18.7% | · | 15.3% | 15.7% | 16.7% | · | 21.1% | 14.7% | 12.0% | · | 19.2% | |
| ROA | 3.6% | 3.0% | · | 4.1% | 2.5% | 1.6% | · | 2.1% | 2.1% | 2.4% | · | 2.1% | 1.9% | 0.92% | · | 2.1% | |
| ROE | 9.6% | 7.6% | · | 12.1% | 7.2% | 4.7% | · | 6.3% | 6.3% | 6.5% | · | 5.9% | 5.3% | 2.2% | · | 5.1% | |
| ROIC | 9.5% | 6.4% | · | 7.2% | 6.2% | 4.0% | · | 5.8% | 5.0% | 5.0% | · | 4.5% | 4.4% | 1.6% | · | 5.6% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.9 | · | 1.6 | 1.5 | 1.5 | · | 2.5 | 2.8 | 2.9 | · | 2.8 | 2.4 | 2.0 | · | 3.8 | |
| Quick Ratio | 1.0 | 1.0 | · | 0.9 | 0.8 | 0.7 | · | 0.9 | 1.1 | 1.1 | · | 0.9 | 0.9 | 0.7 | · | 1.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 22.0 | · | 41.9 | 21.7 | 10.3 | · | 32.1 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | 0.2 | |
| Inventory Turnover | 0.7 | 0.7 | · | 0.8 | 0.8 | 0.8 | · | 0.7 | 0.8 | 0.8 | · | 0.9 | 0.9 | 0.8 | · | 0.8 | |
| Receivables Turnover | 1.0 | 1.1 | · | 1.1 | 1.0 | 1.0 | · | 1.1 | 1.2 | 1.1 | · | 1.4 | 1.3 | 1.3 | · | 1.4 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.95 | $7.66 | · | $6.99 | $6.56 | $5.78 | · | $5.07 | $6.08 | $5.67 | · | $5.87 | $5.44 | $5.76 | · | $4.72 | |
| Revenue / Share | $3.35 | $3.03 | · | $2.97 | $2.83 | $2.54 | · | $2.42 | $2.41 | $2.21 | · | $2.28 | $2.02 | $1.77 | · | $1.81 | |
| Cash Flow / Share | · | $1.34 | · | · | · | $0.45 | · | · | · | $0.50 | · | · | · | $0.37 | · | · | |
| Cash / Share | $2.93 | $2.90 | · | $4.71 | $2.96 | $2.31 | · | $1.59 | $2.34 | $2.15 | · | $1.67 | $3.09 | $1.61 | · | $1.81 | |
| EPS (TTM) | $2.52 | $2.33 | · | $1.79 | $1.43 | $1.33 | · | $1.66 | $1.61 | $1.54 | · | $0.92 | $0.87 | $0.71 | · | $0.16 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.97B | $4.82B | · | $4.52B | $4.30B | $4.15B | · | $3.95B | $3.93B | $3.80B | · | $3.40B | $3.20B | $3.02B | · | $2.79B | |
| Net Income TTM | $1000M | $930M | · | $721M | $572M | $535M | · | $681M | $667M | $639M | · | $377M | $358M | $292M | · | $244M | |
| Market Cap | $25.42B | $24.23B | · | $26.24B | $34.24B | $26.78B | · | $26.19B | $45.43B | $54.94B | · | $36.05B | $49.62B | $45.03B | · | $31.10B | |
| P/E | 26.7 | 27.0 | · | 37.6 | 61.0 | 51.3 | · | 40.4 | 70.4 | 90.1 | · | 101.4 | 147.7 | 163.6 | · | 503.4 | |
| P/S | 5.1 | 5.0 | · | 5.8 | 8.0 | 6.5 | · | 6.6 | 11.5 | 14.5 | · | 10.6 | 15.5 | 14.9 | · | 11.1 | |
| P/B | 9.7 | 8.2 | · | 9.6 | 13.3 | 11.8 | · | 13.2 | 18.7 | 24.5 | · | 15.9 | 23.6 | 20.2 | · | 17.0 | |
| P / Tangible Book | 10.2 | 8.4 | · | 10.0 | 13.9 | 12.5 | · | 14.2 | 19.8 | 26.2 | · | 17.2 | 25.8 | 22.0 | · | 17.5 | |
| P / Cash Flow | · | 46.1 | · | · | · | 145.7 | · | · | · | 262.6 | · | · | · | 289.8 | · | · | |
| Earnings Yield | 3.7% | 3.7% | · | 2.7% | 1.6% | 1.9% | · | 2.5% | 1.4% | 1.1% | · | 0.99% | 0.68% | 0.61% | · | 0.20% |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B |
| Marża Brutto % | 60.1% | 60.5% | 63.2% | 64.7% | 68.6% |
| Marża Operacyjna % | 19.6% | 14.9% | 16.5% | 13.4% | 10.9% |
| Zysk netto | $836M | $576M | $542M | $341M | $217M |
| Rozwodniony EPS | $2.09 | $1.42 | $1.30 | $0.82 | $0.53 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 1.9 | 1.5 | 2.8 | 2.0 | 5.1 |
| Wskaźnik Szybkości | 1.0 | 0.5 | 1.0 | 0.7 | 2.2 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $1.08B | $631M | $512M | $305M | $53M |
Właściciele instytucjonalni (13F) 1 078 emitentów · $29.5B łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
1 078
Wartość posiadanych akcji
$29.5B
Nowe pozycje
125
Zamknięte pozycje
97
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 125 (-42 vs poprzedni kw.) | 97 (+5 vs poprzedni kw.) | 401 (+31 vs poprzedni kw.) | 365 (+14 vs poprzedni kw.) | +13.2M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $3 257 066 468 | 49 074 378 | 11,03% | Akcje |
| BlackRock, Inc. | $2 575 742 626 | 38 244 137 | 8,72% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $1 697 876 797 | 25 209 752 | 5,75% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 323 867 969 | 19 656 540 | 4,48% | Akcje |
| STATE STREET CORP | $1 237 947 284 | 18 380 806 | 4,19% | Akcje |
| Invesco Ltd. | $1 029 655 765 | 15 288 133 | 3,49% | Akcje |
| BAILLIE GIFFORD & CO | $996 887 087 | 14 801 590 | 3,38% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $834 165 910 | 12 426 515 | 2,83% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $734 346 085 | 11 693 409 | 2,49% | Akcje |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $612 059 728 | 9 746 174 | 2,07% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $574 325 172 | 8 527 471 | 1,95% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $462 914 937 | 6 873 273 | 1,57% | Akcje |
| NORGES BANK | $462 565 862 | 6 868 090 | 1,57% | Akcje |
| UBS Group AG | $408 530 217 | 6 065 779 | 1,38% | Akcje |
| Amundi | $377 395 039 | 5 603 490 | 1,28% | Akcje |
| MORGAN STANLEY | $347 275 842 | 5 156 282 | 1,18% | Akcje |
| AMERIPRISE FINANCIAL INC | $324 681 713 | 4 820 775 | 1,10% | Akcje |
| Castle Hook Partners LP | $260 667 534 | 3 870 342 | 0,88% | Akcje |
| GOLDMAN SACHS GROUP INC | $253 142 816 | 3 758 616 | 0,86% | Akcje |
| FRANKLIN RESOURCES INC | $242 183 395 | 3 595 893 | 0,82% | Akcje |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $240 915 152 | 3 560 621 | 0,82% | Akcje |
| CIBC Bancorp USA Inc. | $232 974 509 | 3 454 735 | 0,79% | Akcje |
| JPMORGAN CHASE & CO | $232 690 154 | 3 325 095 | 0,79% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $231 627 696 | 3 439 164 | 0,78% | Akcje |
| NORTHERN TRUST CORP | $221 927 948 | 3 295 144 | 0,75% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $218 060 428 | 3 237 720 | 0,74% | Akcje |
| BANK OF AMERICA CORP /DE/ | $213 068 756 | 3 163 604 | 0,72% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $207 976 113 | 3 087 990 | 0,70% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $206 860 340 | 3 071 423 | 0,70% | Akcje |
| CIBC Private Wealth Group LLC | $195 665 945 | 2 907 801 | 0,66% | Akcje |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $183 859 102 | 2 729 905 | 0,62% | Akcje |
| Legal & General Group Plc | $173 237 203 | 2 572 193 | 0,59% | Akcje |
| JANUS HENDERSON GROUP PLC | $166 077 317 | 2 644 539 | 0,56% | Akcje |
| DEUTSCHE BANK AG\ | $164 034 901 | 2 435 559 | 0,56% | Akcje |
| Bank of New York Mellon Corp | $155 554 805 | 2 309 648 | 0,53% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $152 790 681 | 2 268 607 | 0,52% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $149 327 006 | 2 217 179 | 0,51% | Akcje |
| Employees Provident Fund Board | $147 498 453 | 2 190 029 | 0,50% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $142 152 983 | 2 109 812 | 0,48% | Akcje |
| ROYAL BANK OF CANADA | $137 011 000 | 2 034 290 | 0,46% | Akcje |
| FMR LLC | $127 510 091 | 1 893 246 | 0,43% | Akcje |
| Nuveen, LLC | $123 266 328 | 1 830 235 | 0,42% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $117 263 085 | 1 741 100 | 0,40% | Opcja sprzedaży |
| NOMURA HOLDINGS INC | $115 126 069 | 1 709 370 | 0,39% | Akcje |
| AXA Investment Managers S.A. | $112 203 653 | 1 667 464 | 0,38% | Akcje |
| BLAIR WILLIAM & CO/IL | $112 182 565 | 1 665 665 | 0,38% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $109 834 111 | 1 630 796 | 0,37% | Akcje |
| VICTORY CAPITAL MANAGEMENT INC | $92 130 221 | 1 367 932 | 0,31% | Akcje |
| DSM CAPITAL PARTNERS LLC | $91 537 742 | 1 359 135 | 0,31% | Akcje |
| Mitsubishi UFJ Asset Management Co., Ltd. | $89 939 931 | 1 335 411 | 0,30% | Akcje |
Insiderzy spółki 61 insiderów · 37 dyrektorzy generalni · 26 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jacob Steven Leach | President, CEO, and Director | 22 sierpnia 2026 F | 418 908 | 2 | 0 | $1 001 761 |
| Andrew P Rasdal | President & CEO | 2 maja 2006 M | 2 944 | 0 | 0 | $0 |
| Jess Roper | SVP, CFO | 22 marca 2017 S | 8 452 | 0 | 0 | $0 |
| Steven J Kemper | Chief Financial Officer | 15 maja 2007 A | 26 255 | 0 | 0 | $0 |
| Quentin S. Blackford | Chief Operating Officer | 10 września 2021 S | 19 280 | 0 | 0 | $0 |
| Sadie Stern | EVP Chief People & Culture Off | 28 września 2026 S | 123 478 | 0 | 2 | $-447 644 |
| Michael Jon Brown | EVP Chief Legal Compliance Off | 15 września 2026 S | 99 885 | 0 | 7 | $-873 358 |
| Jereme M Sylvain | EVP, Chief Financal Officer | 10 września 2026 S | 146 828 | 0 | 1 | $-302 936 |
| Kevin R Sayer | Executive Chair | 20 sierpnia 2026 S | 302 214 | 0 | 6 | $-8 303 410 |
| Jon Coleman | EVP, Chief Commercial Officer | 4 czerwca 2026 S | 95 450 | 0 | 2 | $-722 628 |
| Matthew Vincent Dolan | EVP, Strategy & Corporate Dev | 29 stycznia 2025 S | 42 044 | 0 | 0 | $0 |
| Teri L Lawver | EVP Chief Commercial Officer | 12 marca 2024 S | 66 641 | 0 | 0 | $0 |
| Paul R Flynn | EVP Global Revenue | 18 grudnia 2023 D | 48 949 | 0 | 0 | $0 |
| Barry J. Regan | EVP Operations | 18 grudnia 2023 D | 58 469 | 0 | 0 | $0 |
| Steven Robert Pacelli | EVP Managing Director Dexcom V | 24 listopada 2023 S | 124 775 | 0 | 0 | $0 |
| Girish Naganathan | EVP Chief Technology Officer | 9 listopada 2023 S | 47 725 | 0 | 0 | $0 |
| Shelly Ramasamy Selvaraj | SVP Chief Information Officer | 11 września 2023 D | 48 453 | 0 | 0 | $0 |
| Donald Abbey | EVP Global Business Services I | 10 marca 2023 D | 208 023 | 0 | 0 | $0 |
| Andrew K Balo | EVP Regulatory Strategy Clinic | 10 marca 2023 D | 50 908 | 0 | 0 | $0 |
| Chad Patterson | EVP Global Marketing | 9 maja 2022 S | 13 675 | 0 | 0 | $0 |
| Sumi Shrishrimal | SVP Chief Risk Officer | 9 marca 2022 D | 13 789 | 0 | 0 | $0 |
| Patrick Michael Murphy | EVP, Chief Legal Officer | 9 września 2021 S | 16 254 | 0 | 0 | $0 |
| Richard Doubleday | EVP Chief Commercial Officer | 23 marca 2021 S | 6 654 | 0 | 0 | $0 |
| Jeffrey Moy | EVP Operations | 9 września 2020 D | 34 784 | 0 | 0 | $0 |
| Heather S Ace | SVP Human Resources | 11 marca 2020 S | 38 584 | 0 | 0 | $0 |
| Terrance H Gregg | Executive Chairman | 16 lipca 2018 S | 50 882 | 0 | 0 | $0 |
| John Lister | General Manager, EMEA | 9 marca 2017 M | 84 034 | 0 | 0 | $0 |
| Peter Gerhardsson | VP, Int'l Bus. Dev. | 16 listopada 2010 P | 3 387 | 0 | 0 | $0 |
| David Carner | VP, Quality Assurance | 16 sierpnia 2010 A | · | 0 | 0 | $0 |
| Laura Johnson | V.P., Intellectual Property | 12 marca 2010 A | · | 0 | 0 | $0 |
| Richard Yang | V.P., Strategic Affairs | 12 marca 2010 A | · | 0 | 0 | $0 |
| Claudia Graham | VP Marketing | 12 marca 2010 A | 18 741 | 0 | 0 | $0 |
| Rodney L Kellogg | Vice President of Sales | 19 maja 2008 A | · | 0 | 0 | $0 |
| James H Brauker | VP Research & Development | 24 marca 2008 A | 53 125 | 0 | 0 | $0 |
| Mark Brister | VP, Advanced Development Team | 2 listopada 2007 A | 10 967 | 0 | 0 | $0 |
| John Riolo | VP of Quality Assurance | 2 sierpnia 2007 A | · | 0 | 0 | $0 |
| Tae Andrews | Vice President of Marketing | 9 marca 2007 A | · | 0 | 0 | $0 |
| Nicholas Augustinos | Dyrektor | 15 września 2026 S | 29 293 | 0 | 2 | $-679 769 |
| Glenn S Boehnlein | Dyrektor | 10 września 2026 A | 5 841 | 0 | 0 | $0 |
| Bridgette P Heller | Dyrektor | 12 sierpnia 2026 S | 29 570 | 0 | 4 | $-277 672 |
| Mark G Foletta | Dyrektor | 3 sierpnia 2026 S | 48 852 | 0 | 4 | $-627 183 |
| Albert Frederick Osterloh IV | Dyrektor | 28 maja 2026 A | 8 691 | 0 | 0 | $0 |
| Euan A. Ashley | Dyrektor | 28 maja 2026 A | 12 731 | 0 | 0 | $0 |
| Rimma Driscoll | Dyrektor | 28 maja 2026 A | 17 319 | 0 | 0 | $0 |
| Kyle Malady | Dyrektor | 28 maja 2026 A | 28 242 | 0 | 0 | $0 |
| Richard Alexander Collins | Dyrektor | 28 maja 2026 A | 5 605 | 0 | 2 | $-389 410 |
| Renee D Gala | Dyrektor | 28 maja 2026 A | 12 486 | 0 | 0 | $0 |
| Steven R Altman | Dyrektor | 28 maja 2026 A | 5 565 | 0 | 0 | $0 |
| Karen M Dahut | Dyrektor | 8 maja 2025 G | 17 779 | 0 | 0 | $0 |
| Eric Topol | Dyrektor | 8 maja 2025 G | 380 545 | 0 | 0 | $0 |
| Barbara Kahn | Dyrektor | 18 maja 2024 G | 22 575 | 0 | 0 | $0 |
| Jay S Skyler | Dyrektor | 18 maja 2023 G | 63 348 | 0 | 0 | $0 |
| Jonathan T Lord MD | Dyrektor | 1 września 2016 S | 52 820 | 0 | 0 | $0 |
| Martin Doordan | Dyrektor | 1 czerwca 2012 A | 39 633 | 0 | 0 | $0 |
| Donald A Lucas | Dyrektor | 19 maja 2010 A | 16 448 | 0 | 0 | $0 |
| Donald L Lucas | Dyrektor | 15 marca 2010 S | 69 076 | 0 | 0 | $0 |
| Sean Carney | Dyrektor | 19 maja 2008 A | 20 285 | 0 | 0 | $0 |
| Glen D Nelson | Dyrektor | 14 marca 2008 P | 170 654 | 0 | 0 | $0 |
| Kim D Blickenstaff | Dyrektor | 23 maja 2007 A | 4 104 | 0 | 0 | $0 |
| Brenton Karl Ahrens | Dyrektor | 13 kwietnia 2006 A | 280 619 | 0 | 0 | $0 |
| Jorge A Valdes | · | 13 marca 2017 S | 10 442 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 132 fundusze ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| IHI · iShares Trust | 4,91% | 1 844 741 SH | 11 września 2026 | Dziennie |
| JMID · Janus Detroit Street Trust | 2,74% | 7 762 NS | 31 lipca 2026 | N-PORT |
| FGSI · First Trust Exchange-Traded Fund IV | 2,12% | 527 NS | 31 lipca 2026 | N-PORT |
| QQQG · Pacer Funds Trust | 2,04% | 4 976 NS | 31 lipca 2026 | N-PORT |
| ABOT · Abacus FCF ETF Trust | 1,96% | 948 NS | 31 lipca 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,68% | 170 219 SH | 1 października 2026 | Dziennie |
| SPGP · Invesco Exchange-Traded Fund Trust | 1,59% | 374 143 SH | 1 października 2026 | Dziennie |
| AGRW · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 1,28% | 17 329 NS | 31 lipca 2026 | N-PORT |
| COWG · Pacer Funds Trust | 1,15% | 305 526 NS | 31 lipca 2026 | N-PORT |
| QQQE · Direxion Shares ETF Trust | 1,15% | 184 331 NS | 31 lipca 2026 | N-PORT |
| RILA · Spinnaker ETF Series | 1,01% | 5 118 NS | 31 lipca 2026 | N-PORT |
| IWP · iShares Trust | 0,95% | 2 162 676 SH | 11 września 2026 | Dziennie |
| QFLR · Innovator ETFs Trust | 0,93% | 58 151 NS | 31 lipca 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0,81% | 20 420 NS | 31 lipca 2026 | N-PORT |
| MEDI · Harbor ETF Trust | 0,81% | 3 979 NS | 31 lipca 2026 | N-PORT |
| QNXT · iShares Trust | 0,62% | 2 014 SH | 11 września 2026 | Dziennie |
| SDG · iShares Trust | 0,60% | 11 793 SH | 11 września 2026 | Dziennie |
| VOT · VANGUARD INDEX FUNDS | 0,57% | 2 956 203 SH | 19 sierpnia 2026 | Dziennie |
| QIDX · Spinnaker ETF Series | 0,55% | 2 575 NS | 31 lipca 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,52% | 65 774 NS | 31 lipca 2026 | N-PORT |
| IYH · iShares Trust | 0,52% | 224 542 SH | 11 września 2026 | Dziennie |
| COWZ · Pacer Funds Trust | 0,49% | 1 097 680 NS | 31 lipca 2026 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,48% | 76 326 NS | 31 lipca 2026 | N-PORT |
| SPHQ · Invesco Exchange-Traded Fund Trust | 0,48% | 1 038 503 SH | 1 października 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 0,46% | 183 141 NS | 31 lipca 2026 | N-PORT |
| IMCG · iShares Trust | 0,45% | 213 189 SH | 11 września 2026 | Dziennie |
| IXJ · iShares Trust | 0,41% | 203 560 SH | 11 września 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,38% | 1 156 710 SH | 19 sierpnia 2026 | Dziennie |
| CURE · Direxion Shares ETF Trust | 0,37% | 7 593 NS | 31 lipca 2026 | N-PORT |
| VFQY · VANGUARD WELLINGTON FUND | 0,34% | 23 742 SH | 19 sierpnia 2026 | Dziennie |
| RECS · Columbia ETF Trust I | 0,27% | 187 634 NS | 31 lipca 2026 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0,25% | 8 362 213 SH | 19 sierpnia 2026 | Dziennie |
| SIZE · iShares Trust | 0,24% | 12 297 SH | 11 września 2026 | Dziennie |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,24% | 16 587 NS | 31 lipca 2026 | N-PORT |
| IWR · iShares Trust | 0,24% | 1 572 597 SH | 11 września 2026 | Dziennie |
| IMCB · iShares Trust | 0,23% | 45 160 SH | 11 września 2026 | Dziennie |
| ESUM · Strategy Shares | 0,23% | 4 954 NS | 31 lipca 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,21% | 2 334 278 SH | 1 października 2026 | Dziennie |
| ESLG · Strategy Shares | 0,20% | 561 NS | 31 lipca 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,19% | 43 412 SH | 11 września 2026 | Dziennie |
| JQUA · J.P. Morgan Exchange-Traded Fund Tr… | 0,18% | 181 851 NS | 31 lipca 2026 | N-PORT |
| XOEF · iShares Trust | 0,18% | 485 SH | 11 września 2026 | Dziennie |
| LRND · New York Life Investments ETF Trust | 0,18% | 8 712 NS | 31 lipca 2026 | N-PORT |
| CATH · Global X Funds | 0,15% | 23 840 NS | 31 lipca 2026 | N-PORT |
| QYLG · Global X Funds | 0,15% | 2 837 NS | 31 lipca 2026 | N-PORT |
| PTNQ · Pacer Funds Trust | 0,15% | 21 359 NS | 31 lipca 2026 | N-PORT |
| QTR · Global X Funds | 0,15% | 136 NS | 31 lipca 2026 | N-PORT |
| QQWZ · Pacer Funds Trust | 0,15% | 895 NS | 31 lipca 2026 | N-PORT |
| QYLD · Global X Funds | 0,15% | 141 287 NS | 31 lipca 2026 | N-PORT |
| QCLR · Global X Funds | 0,14% | 57 NS | 31 lipca 2026 | N-PORT |
| QRMI · Global X Funds | 0,14% | 246 NS | 31 lipca 2026 | N-PORT |
| QQQM · Invesco Exchange-Traded Fund Trust … | 0,14% | 1 734 337 SH | 1 października 2026 | Dziennie |
| QQQ · Invesco QQQ Trust, Series 1 | 0,14% | 7 879 739 SH | 1 października 2026 | Dziennie |
| QSIX · Pacer Funds Trust | 0,14% | 298 NS | 31 lipca 2026 | N-PORT |
| USXF · iShares Trust | 0,13% | 22 924 SH | 11 września 2026 | Dziennie |
| QUAL · iShares Trust | 0,12% | 666 753 SH | 11 września 2026 | Dziennie |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,11% | 20 921 NS | 31 lipca 2026 | N-PORT |
| GARP · iShares Trust | 0,11% | 40 229 SH | 11 września 2026 | Dziennie |
| DXUV · Dimensional ETF Trust | 0,11% | 7 089 NS | 31 lipca 2026 | N-PORT |
| INFO · Harbor ETF Trust | 0,11% | 10 730 NS | 31 lipca 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,10% | 56 508 SH | 1 października 2026 | Dziennie |
| ILCG · iShares Trust | 0,10% | 37 554 SH | 11 września 2026 | Dziennie |
| AQLT · iShares Trust | 0,10% | 3 937 SH | 11 września 2026 | Dziennie |
| IQSU · New York Life Investments ETF Trust | 0,10% | 3 878 NS | 31 lipca 2026 | N-PORT |
| IWF · iShares Trust | 0,10% | 1 441 625 SH | 11 września 2026 | Dziennie |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 8 929 SH | 1 października 2026 | Dziennie |
| CHRI · Global X Funds | 0,10% | 93 NS | 31 lipca 2026 | N-PORT |
| DSI · iShares Trust | 0,09% | 58 749 SH | 11 września 2026 | Dziennie |
| VUG · VANGUARD INDEX FUNDS | 0,09% | 4 943 048 SH | 19 sierpnia 2026 | Dziennie |
| DFAC · Dimensional ETF Trust | 0,09% | 499 383 NS | 31 lipca 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,09% | 23 598 NS | 31 lipca 2026 | N-PORT |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,08% | 603 971 SH | 19 sierpnia 2026 | Dziennie |
| WRND · New York Life Investments ETF Trust | 0,08% | 100 NS | 31 lipca 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,08% | 31 150 NS | 31 lipca 2026 | N-PORT |
| EGLE · Global X Funds | 0,08% | 20 NS | 31 lipca 2026 | N-PORT |
| GLBL · Pacer Funds Trust | 0,08% | 10 NS | 31 lipca 2026 | N-PORT |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,06% | 12 002 SH | 1 października 2026 | Dziennie |
| TOPC · iShares Trust | 0,06% | 230 SH | 11 września 2026 | Dziennie |
| XVV · iShares Trust | 0,06% | 4 446 SH | 11 września 2026 | Dziennie |
| XRMI · Global X Funds | 0,06% | 333 NS | 31 lipca 2026 | N-PORT |
| XTR · Global X Funds | 0,06% | 32 NS | 31 lipca 2026 | N-PORT |
| XCLR · Global X Funds | 0,05% | 23 NS | 31 lipca 2026 | N-PORT |
| IVE · iShares Trust | 0,05% | 312 923 SH | 11 września 2026 | Dziennie |
| XYLG · Global X Funds | 0,05% | 394 NS | 31 lipca 2026 | N-PORT |
| XYLD · Global X Funds | 0,05% | 19 868 NS | 31 lipca 2026 | N-PORT |
| IUSV · iShares Trust | 0,05% | 165 780 SH | 11 września 2026 | Dziennie |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,05% | 66 672 SH | 1 października 2026 | Dziennie |
| PBP · Invesco Exchange-Traded Fund Trust | 0,05% | 2 246 SH | 1 października 2026 | Dziennie |
| TOV · EA Series Trust | 0,05% | 1 441 NS | 31 lipca 2026 | N-PORT |
| ACVF · ETF Opportunities Trust | 0,05% | 912 NS | 31 lipca 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0,05% | 32 725 NS | 31 lipca 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,05% | 53 113 NS | 31 lipca 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,05% | 19 478 NS | 31 lipca 2026 | N-PORT |
| IVV · iShares Trust | 0,05% | 4 868 303 SH | 11 września 2026 | Dziennie |
| DFVX · Dimensional ETF Trust | 0,05% | 3 126 NS | 31 lipca 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,05% | 6 516 NS | 31 lipca 2026 | N-PORT |
| ILCB · iShares Trust | 0,05% | 7 544 SH | 11 września 2026 | Dziennie |
| DFUS · Dimensional ETF Trust | 0,05% | 120 564 NS | 31 lipca 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,05% | 5 338 SH | 30 września 2026 | Dziennie |
| VOXP · Advisors Series Trust | 0,05% | 33 NS | 31 lipca 2026 | N-PORT |
| IVW · iShares Trust | 0,05% | 421 263 SH | 11 września 2026 | Dziennie |
| IYY · iShares Trust | 0,05% | 16 523 SH | 11 września 2026 | Dziennie |
| IWB · iShares Trust | 0,05% | 264 795 SH | 11 września 2026 | Dziennie |
| SPUU · Direxion Shares ETF Trust | 0,05% | 1 456 NS | 31 lipca 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0,05% | 9 285 NS | 31 lipca 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,05% | 67 183 NS | 31 lipca 2026 | N-PORT |
| IUSG · iShares Trust | 0,04% | 173 802 SH | 11 września 2026 | Dziennie |
| ITOT · iShares Trust | 0,04% | 499 542 SH | 11 września 2026 | Dziennie |
| IWV · iShares Trust | 0,04% | 104 639 SH | 11 września 2026 | Dziennie |
| PHDG · Invesco Actively Managed Exchange-T… | 0,04% | 297 SH | 1 października 2026 | Dziennie |
| VOO · VANGUARD INDEX FUNDS | 0,04% | 10 024 256 SH | 19 sierpnia 2026 | Dziennie |
| VV · VANGUARD INDEX FUNDS | 0,04% | 450 660 SH | 19 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,04% | 12 252 641 SH | 19 sierpnia 2026 | Dziennie |
| VOOG · VANGUARD ADMIRAL FUNDS | 0,04% | 146 079 SH | 19 sierpnia 2026 | Dziennie |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,04% | 43 354 SH | 19 sierpnia 2026 | Dziennie |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,04% | 63 234 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,04% | 32 310 SH | 19 sierpnia 2026 | Dziennie |
| ESGV · VANGUARD WORLD FUND | 0,04% | 86 728 SH | 19 sierpnia 2026 | Dziennie |
| HCMT · Direxion Shares ETF Trust | 0,04% | 2 682 NS | 31 lipca 2026 | N-PORT |
| TOK · iShares Trust | 0,04% | 1 068 SH | 11 września 2026 | Dziennie |
| SPXL · Direxion Shares ETF Trust | 0,04% | 30 165 NS | 31 lipca 2026 | N-PORT |
| URTH · iShares, Inc. | 0,04% | 34 971 SH | 11 września 2026 | Dziennie |
| TILT · FlexShares Trust | 0,03% | 8 908 NS | 31 lipca 2026 | N-PORT |
| ACWI · iShares Trust | 0,03% | 121 058 SH | 11 września 2026 | Dziennie |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,03% | 29 537 SH | 1 października 2026 | Dziennie |
| PRF · Invesco Exchange-Traded Fund Trust | 0,03% | 28 890 SH | 1 października 2026 | Dziennie |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,02% | 323 858 SH | 19 sierpnia 2026 | Dziennie |
| DYNF · BlackRock ETF Trust | 0,02% | 87 332 SH | 11 września 2026 | Dziennie |
| USCL · iShares Trust | 0,02% | 5 063 SH | 11 września 2026 | Dziennie |
| LGDX · Tidal Trust III | 0,01% | 229 NS | 31 lipca 2026 | N-PORT |
| CRBN · iShares Trust | 0,01% | 1 408 SH | 11 września 2026 | Dziennie |
| PEVC · Pacer Funds Trust | 0,00% | 1 NS | 31 lipca 2026 | N-PORT |
DXCM Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 36 analityków
KUP
Średni cel
$95.00
+11,3%
15 41,7%
Mocne kupno
16 44,4%
Kup
5 13,9%
Trzymaj
0 0,0%
Sprzedaj
0 0,0%
Mocna sprzedaż
12-miesięczny cel cenowy
25 analityków · 2026-10-02Średnia cel $95.08 +11,4%
Teraz
Aktualna cena $85.36
Niski$79.00
Średnia$95.08
Wysoki$115.00
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| SYK | $134.44B | 41.8 | 11.2% | 12.9% | 15.1% | 64.0% |
| BSX | · | 49.1 | 19.9% | 14.4% | 12.6% | 69.0% |
| EW | $49.50B | 46.6 | 11.6% | 17.7% | 10.6% | 78.0% |
| BDX | · | 25.3 | 8.2% | 7.7% | 6.5% | · |
| IDXX | $53.93B | 51.7 | 10.4% | 24.6% | 69.2% | 61.8% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| GEHC | · | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | · |
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
DexCom (DXCM) Wypowiada się optymistycznie o 2026, Wzrasta o 6,6%
Yahoo Finance · 4 miesiące, 2 tygodnie temu
Czy analitycy z Wall Street są optymistyczni co do akcji DexCom?
Yahoo Finance · 4 miesiące, 2 tygodnie temu
DexCom (DXCM) raportuje przychody za Q1 2026 w wysokości 1,19 mld USD ze wzrostem o 15%
Yahoo Finance · 4 miesiące, 3 tygodnie temu
Sygnały transakcyjne Ostatnie sygnały kupna/sprzedaży z ceną wejścia i wskaźnikiem ryzyka/zysku
BLUECHIP_DIP
Zrealizowano stop loss
ryzyko 1
nagroda 1,92
wejście
$64.82
R:R 1,92
BLUECHIP_DIP
Zrealizowano stop loss
ryzyko 1
nagroda 1,85
wejście
$65.02
R:R 1,85
RANGE
Zrealizowano stop loss
ryzyko 1
nagroda 4,99
wejście
$63.32
R:R 4,99
Obecnie brak otwartego sygnału — żadna karta nie jest wypełniona, i to jest uczciwe.
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Lip 30, 2026